Our study presents a novel mitochondrial dysfunction-mediated retrograde signaling pathway and the resulting transcriptomic reprogramming in liver cancer progression, providing the NDUFA9/NFE2L1/STX12 axis as a key prognostic marker of aggressive liver cancer with mitochondrial defects. The gene discussed is STX12; the disease is liver cancer.